Cargando…
Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report
We present the case of a 24-year-old Caucasian man, who developed a scaly erythematous skin rash after the second dose of coronavirus disease 2019 (COVID-19) vaccination with Comirnaty (BNT162b2, BioNTech/Pfizer; Pfizer, New York, NY, USA) and proved positive for Epstein-Barr virus (EBV) reactivatio...
Autores principales: | Herzum, Astrid, Trave, Ilaria, D’Agostino, Federica, Burlando, Martina, Cozzani, Emanuele, Parodi, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200649/ https://www.ncbi.nlm.nih.gov/pubmed/35799871 http://dx.doi.org/10.7774/cevr.2022.11.2.222 |
Ejemplares similares
-
Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80
por: Burlando, Martina, et al.
Publicado: (2021) -
Results of COVID-19 screening in a dermatologic clinic in Northern Italy
por: BURLANDO, MARTINA, et al.
Publicado: (2023) -
Comedonal variant of chronic cutaneous lupus erythematosus causing mutilation of the earlobe
por: Cozzani, Emanuele, et al.
Publicado: (2020) -
The 30th birthday of chronic ulcerative stomatitis: A systematic review
por: Herzum, Astrid, et al.
Publicado: (2021) -
Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study
por: Burlando, Martina, et al.
Publicado: (2023)